Synapto-protective drugs evaluation in reconstructed neuronal network
Identifieur interne : 000980 ( Hal/Curation ); précédent : 000979; suivant : 000981Synapto-protective drugs evaluation in reconstructed neuronal network
Auteurs : Bérangère Deleglise [France] ; Benjamin Lassus [France] ; Vanessa Soubeyre [France] ; Aurélie Alleaume-Butaux [France] ; Johannes J. Hjorth [Pays-Bas] ; Maeva Vignes [France] ; Benoit Schneider [France] ; Bernard Brugg [France] ; Jean-Louis Viovy [France] ; Jean-Michel Peyrin [France]Source :
- PLoS ONE [ 1932-6203 ] ; 2013.
Abstract
Chronic neurodegenerative syndromes such as Alzheimer’s and Parkinson’s diseases, or acute syndromes such as ischemic stroke or traumatic brain injuries are characterized by early synaptic collapse which precedes axonal and neuronal cell body degeneration and promotes early cognitive impairment in patients. Until now, neuroprotective strategies have failed to impede the progression of neurodegenerative syndromes. Drugs preventing the loss of cell body do not prevent the cognitive decline, probably because they lack synapto-protective effects. The absence of physiologically realistic neuronal network models which can be easily handled has hindered the development of synapto-protective drugs suitable for therapies. Here we describe a new microfluidic platform which makes it possible to study the consequences of axonal trauma of reconstructed oriented mouse neuronal networks. Each neuronal population and sub-compartment can be chemically addressed individually. The somatic, mid axon, presynaptic and postsynaptic effects of local pathological stresses or putative protective molecules can thus be evaluated with the help of this versatile “brain on chip” platform. We show that presynaptic loss is the earliest event observed following axotomy of cortical fibers, before any sign of axonal fragmentation or post-synaptic spine alteration. This platform can be used to screen and evaluate the synapto-protective potential of several drugs. For instance, NAD+ and the Rho-kinase inhibitor Y27632 can efficiently prevent synaptic disconnection, whereas the broad-spectrum caspase inhibitor zVAD-fmk and the stilbenoid resveratrol do not prevent presynaptic degeneration. Hence, this platform is a promising tool for fundamental research in the field of developmental and neurodegenerative neurosciences, and also offers the opportunity to set up pharmacological screening of axon-protective and synapto-protective drugs.
Url:
DOI: 10.1371/journal.pone.0071103
Links toward previous steps (curation, corpus...)
- to stream Hal, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000A73
Links to Exploration step
Hal:hal-01221378Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Synapto-protective drugs evaluation in reconstructed neuronal network</title>
<author><name sortKey="Deleglise, Berangere" sort="Deleglise, Berangere" uniqKey="Deleglise B" first="Bérangère" last="Deleglise">Bérangère Deleglise</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-440810" status="INCOMING"> <orgName>UMR7102 Neurobiologie des Processus Adaptatifs</orgName>
<desc> <address> <country key="FR"></country>
</address>
</desc>
<listRelation> <relation active="#struct-93591" type="direct"></relation>
<relation active="#struct-479809" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-93591" type="direct"><org type="institution" xml:id="struct-93591" status="VALID"> <orgName>Université Pierre et Marie Curie - Paris 6</orgName>
<orgName type="acronym">UPMC</orgName>
<desc> <address> <addrLine>4 place Jussieu - 75005 Paris</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.upmc.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-479809" type="direct"><org type="institution" xml:id="struct-479809" status="INCOMING"> <orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<desc> <address> <country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Lassus, Benjamin" sort="Lassus, Benjamin" uniqKey="Lassus B" first="Benjamin" last="Lassus">Benjamin Lassus</name>
<affiliation wicri:level="1"><hal:affiliation type="institution" xml:id="struct-479809" status="INCOMING"> <orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<desc> <address> <country key="FR"></country>
</address>
</desc>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Soubeyre, Vanessa" sort="Soubeyre, Vanessa" uniqKey="Soubeyre V" first="Vanessa" last="Soubeyre">Vanessa Soubeyre</name>
<affiliation wicri:level="1"><hal:affiliation type="institution" xml:id="struct-479809" status="INCOMING"> <orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<desc> <address> <country key="FR"></country>
</address>
</desc>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Alleaume Butaux, Aurelie" sort="Alleaume Butaux, Aurelie" uniqKey="Alleaume Butaux A" first="Aurélie" last="Alleaume-Butaux">Aurélie Alleaume-Butaux</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-440811" status="INCOMING"> <orgName>UMR-S 747, Sorbonne Paris Cité </orgName>
<desc> <address> <country key="FR"></country>
</address>
</desc>
<listRelation> <relation active="#struct-301361" type="direct"></relation>
<relation active="#struct-301664" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-301361" type="direct"><org type="institution" xml:id="struct-301361" status="VALID"> <orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<desc> <address> <country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle active="#struct-301664" type="direct"><org type="institution" xml:id="struct-301664" status="VALID"> <idno type="IdRef">026404788</idno>
<idno type="ISNI">0000 0001 2188 0914 </idno>
<orgName>Université Paris Descartes - Paris 5</orgName>
<orgName type="acronym">UPD5</orgName>
<desc> <address> <addrLine>12, rue de l'École de Médecine - 75270 Paris cedex 06</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.parisdescartes.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Hjorth, Johannes J" sort="Hjorth, Johannes J" uniqKey="Hjorth J" first="Johannes J." last="Hjorth">Johannes J. Hjorth</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-440814" status="INCOMING"> <orgName>Integrative Neurophysiology</orgName>
<desc> <address> <country key="NL"></country>
</address>
</desc>
<listRelation> <relation active="#struct-440812" type="direct"></relation>
<relation active="#struct-440813" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-440812" type="direct"><org type="institution" xml:id="struct-440812" status="INCOMING"> <orgName>Conseil National de Concertation et de coopération des Ruraux</orgName>
<orgName type="acronym">CNCR</orgName>
<desc> <address> <country key="NL"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle active="#struct-440813" type="direct"><org type="researchteam" xml:id="struct-440813" status="INCOMING"> <orgName>VU University Amsterdam</orgName>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Pays-Bas</country>
</affiliation>
</author>
<author><name sortKey="Vignes, Maeva" sort="Vignes, Maeva" uniqKey="Vignes M" first="Maeva" last="Vignes">Maeva Vignes</name>
<affiliation wicri:level="1"><hal:affiliation type="institution" xml:id="struct-479809" status="INCOMING"> <orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<desc> <address> <country key="FR"></country>
</address>
</desc>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Schneider, Benoit" sort="Schneider, Benoit" uniqKey="Schneider B" first="Benoit" last="Schneider">Benoit Schneider</name>
<affiliation wicri:level="1"><hal:affiliation type="institution" xml:id="struct-301361" status="VALID"> <orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<desc> <address> <country key="FR"></country>
</address>
</desc>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Brugg, Bernard" sort="Brugg, Bernard" uniqKey="Brugg B" first="Bernard" last="Brugg">Bernard Brugg</name>
<affiliation wicri:level="1"><hal:affiliation type="institution" xml:id="struct-479809" status="INCOMING"> <orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<desc> <address> <country key="FR"></country>
</address>
</desc>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Viovy, Jean Louis" sort="Viovy, Jean Louis" uniqKey="Viovy J" first="Jean-Louis" last="Viovy">Jean-Louis Viovy</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-440815" status="INCOMING"> <orgName>UMR168 Macromolécules et Microsystèmes</orgName>
<desc> <address> <country key="FR"></country>
</address>
</desc>
<listRelation> <relation active="#struct-434363" type="direct"></relation>
<relation active="#struct-479809" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-434363" type="direct"><org type="researchteam" xml:id="struct-434363" status="INCOMING"> <orgName>Institut Curie</orgName>
</org>
</tutelle>
<tutelle active="#struct-479809" type="direct"><org type="institution" xml:id="struct-479809" status="INCOMING"> <orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<desc> <address> <country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Peyrin, Jean Michel" sort="Peyrin, Jean Michel" uniqKey="Peyrin J" first="Jean-Michel" last="Peyrin">Jean-Michel Peyrin</name>
<affiliation wicri:level="1"><hal:affiliation type="institution" xml:id="struct-479809" status="INCOMING"> <orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<desc> <address> <country key="FR"></country>
</address>
</desc>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">HAL</idno>
<idno type="RBID">Hal:hal-01221378</idno>
<idno type="halId">hal-01221378</idno>
<idno type="halUri">https://hal.archives-ouvertes.fr/hal-01221378</idno>
<idno type="url">https://hal.archives-ouvertes.fr/hal-01221378</idno>
<idno type="doi">10.1371/journal.pone.0071103</idno>
<date when="2013">2013</date>
<idno type="wicri:Area/Hal/Corpus">000A73</idno>
<idno type="wicri:Area/Hal/Curation">000A73</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Synapto-protective drugs evaluation in reconstructed neuronal network</title>
<author><name sortKey="Deleglise, Berangere" sort="Deleglise, Berangere" uniqKey="Deleglise B" first="Bérangère" last="Deleglise">Bérangère Deleglise</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-440810" status="INCOMING"> <orgName>UMR7102 Neurobiologie des Processus Adaptatifs</orgName>
<desc> <address> <country key="FR"></country>
</address>
</desc>
<listRelation> <relation active="#struct-93591" type="direct"></relation>
<relation active="#struct-479809" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-93591" type="direct"><org type="institution" xml:id="struct-93591" status="VALID"> <orgName>Université Pierre et Marie Curie - Paris 6</orgName>
<orgName type="acronym">UPMC</orgName>
<desc> <address> <addrLine>4 place Jussieu - 75005 Paris</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.upmc.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-479809" type="direct"><org type="institution" xml:id="struct-479809" status="INCOMING"> <orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<desc> <address> <country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Lassus, Benjamin" sort="Lassus, Benjamin" uniqKey="Lassus B" first="Benjamin" last="Lassus">Benjamin Lassus</name>
<affiliation wicri:level="1"><hal:affiliation type="institution" xml:id="struct-479809" status="INCOMING"> <orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<desc> <address> <country key="FR"></country>
</address>
</desc>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Soubeyre, Vanessa" sort="Soubeyre, Vanessa" uniqKey="Soubeyre V" first="Vanessa" last="Soubeyre">Vanessa Soubeyre</name>
<affiliation wicri:level="1"><hal:affiliation type="institution" xml:id="struct-479809" status="INCOMING"> <orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<desc> <address> <country key="FR"></country>
</address>
</desc>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Alleaume Butaux, Aurelie" sort="Alleaume Butaux, Aurelie" uniqKey="Alleaume Butaux A" first="Aurélie" last="Alleaume-Butaux">Aurélie Alleaume-Butaux</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-440811" status="INCOMING"> <orgName>UMR-S 747, Sorbonne Paris Cité </orgName>
<desc> <address> <country key="FR"></country>
</address>
</desc>
<listRelation> <relation active="#struct-301361" type="direct"></relation>
<relation active="#struct-301664" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-301361" type="direct"><org type="institution" xml:id="struct-301361" status="VALID"> <orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<desc> <address> <country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle active="#struct-301664" type="direct"><org type="institution" xml:id="struct-301664" status="VALID"> <idno type="IdRef">026404788</idno>
<idno type="ISNI">0000 0001 2188 0914 </idno>
<orgName>Université Paris Descartes - Paris 5</orgName>
<orgName type="acronym">UPD5</orgName>
<desc> <address> <addrLine>12, rue de l'École de Médecine - 75270 Paris cedex 06</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.parisdescartes.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Hjorth, Johannes J" sort="Hjorth, Johannes J" uniqKey="Hjorth J" first="Johannes J." last="Hjorth">Johannes J. Hjorth</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-440814" status="INCOMING"> <orgName>Integrative Neurophysiology</orgName>
<desc> <address> <country key="NL"></country>
</address>
</desc>
<listRelation> <relation active="#struct-440812" type="direct"></relation>
<relation active="#struct-440813" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-440812" type="direct"><org type="institution" xml:id="struct-440812" status="INCOMING"> <orgName>Conseil National de Concertation et de coopération des Ruraux</orgName>
<orgName type="acronym">CNCR</orgName>
<desc> <address> <country key="NL"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle active="#struct-440813" type="direct"><org type="researchteam" xml:id="struct-440813" status="INCOMING"> <orgName>VU University Amsterdam</orgName>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Pays-Bas</country>
</affiliation>
</author>
<author><name sortKey="Vignes, Maeva" sort="Vignes, Maeva" uniqKey="Vignes M" first="Maeva" last="Vignes">Maeva Vignes</name>
<affiliation wicri:level="1"><hal:affiliation type="institution" xml:id="struct-479809" status="INCOMING"> <orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<desc> <address> <country key="FR"></country>
</address>
</desc>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Schneider, Benoit" sort="Schneider, Benoit" uniqKey="Schneider B" first="Benoit" last="Schneider">Benoit Schneider</name>
<affiliation wicri:level="1"><hal:affiliation type="institution" xml:id="struct-301361" status="VALID"> <orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<desc> <address> <country key="FR"></country>
</address>
</desc>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Brugg, Bernard" sort="Brugg, Bernard" uniqKey="Brugg B" first="Bernard" last="Brugg">Bernard Brugg</name>
<affiliation wicri:level="1"><hal:affiliation type="institution" xml:id="struct-479809" status="INCOMING"> <orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<desc> <address> <country key="FR"></country>
</address>
</desc>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Viovy, Jean Louis" sort="Viovy, Jean Louis" uniqKey="Viovy J" first="Jean-Louis" last="Viovy">Jean-Louis Viovy</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-440815" status="INCOMING"> <orgName>UMR168 Macromolécules et Microsystèmes</orgName>
<desc> <address> <country key="FR"></country>
</address>
</desc>
<listRelation> <relation active="#struct-434363" type="direct"></relation>
<relation active="#struct-479809" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-434363" type="direct"><org type="researchteam" xml:id="struct-434363" status="INCOMING"> <orgName>Institut Curie</orgName>
</org>
</tutelle>
<tutelle active="#struct-479809" type="direct"><org type="institution" xml:id="struct-479809" status="INCOMING"> <orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<desc> <address> <country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Peyrin, Jean Michel" sort="Peyrin, Jean Michel" uniqKey="Peyrin J" first="Jean-Michel" last="Peyrin">Jean-Michel Peyrin</name>
<affiliation wicri:level="1"><hal:affiliation type="institution" xml:id="struct-479809" status="INCOMING"> <orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<desc> <address> <country key="FR"></country>
</address>
</desc>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
</analytic>
<idno type="DOI">10.1371/journal.pone.0071103</idno>
<series><title level="j">PLoS ONE</title>
<idno type="ISSN">1932-6203</idno>
<imprint><date type="datePub">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Chronic neurodegenerative syndromes such as Alzheimer’s and Parkinson’s diseases, or acute syndromes such as ischemic stroke or traumatic brain injuries are characterized by early synaptic collapse which precedes axonal and neuronal cell body degeneration and promotes early cognitive impairment in patients. Until now, neuroprotective strategies have failed to impede the progression of neurodegenerative syndromes. Drugs preventing the loss of cell body do not prevent the cognitive decline, probably because they lack synapto-protective effects. The absence of physiologically realistic neuronal network models which can be easily handled has hindered the development of synapto-protective drugs suitable for therapies. Here we describe a new microfluidic platform which makes it possible to study the consequences of axonal trauma of reconstructed oriented mouse neuronal networks. Each neuronal population and sub-compartment can be chemically addressed individually. The somatic, mid axon, presynaptic and postsynaptic effects of local pathological stresses or putative protective molecules can thus be evaluated with the help of this versatile “brain on chip” platform. We show that presynaptic loss is the earliest event observed following axotomy of cortical fibers, before any sign of axonal fragmentation or post-synaptic spine alteration. This platform can be used to screen and evaluate the synapto-protective potential of several drugs. For instance, NAD+ and the Rho-kinase inhibitor Y27632 can efficiently prevent synaptic disconnection, whereas the broad-spectrum caspase inhibitor zVAD-fmk and the stilbenoid resveratrol do not prevent presynaptic degeneration. Hence, this platform is a promising tool for fundamental research in the field of developmental and neurodegenerative neurosciences, and also offers the opportunity to set up pharmacological screening of axon-protective and synapto-protective drugs.</div>
</front>
</TEI>
<hal api="V3"> <titleStmt> <title xml:lang="en">Synapto-protective drugs evaluation in reconstructed neuronal network</title>
<author role="aut"> <persName> <forename type="first">Bérangère</forename>
<surname>Deleglise</surname>
</persName>
<idno type="halauthorid">1239238</idno>
<affiliation ref="#struct-440810"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Benjamin</forename>
<surname>Lassus</surname>
</persName>
<idno type="halauthorid">1239259</idno>
<affiliation ref="#struct-479809"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Vanessa</forename>
<surname>Soubeyre</surname>
</persName>
<idno type="halauthorid">1239241</idno>
<affiliation ref="#struct-479809"></affiliation>
<affiliation ref="#struct-440796"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Aurélie</forename>
<surname>Alleaume-Butaux</surname>
</persName>
<idno type="halauthorid">1239260</idno>
<affiliation ref="#struct-440811"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Johannes J.</forename>
<surname>Hjorth</surname>
</persName>
<idno type="halauthorid">1239261</idno>
<affiliation ref="#struct-440814"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Maeva</forename>
<surname>Vignes</surname>
</persName>
<idno type="halauthorid">1239242</idno>
<affiliation ref="#struct-479809"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Benoit</forename>
<surname>Schneider</surname>
</persName>
<idno type="halauthorid">1239262</idno>
<affiliation ref="#struct-301361"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Bernard</forename>
<surname>Brugg</surname>
</persName>
<idno type="halauthorid">156468</idno>
<affiliation ref="#struct-479809"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Jean-Louis</forename>
<surname>Viovy</surname>
</persName>
<idno type="halauthorid">118899</idno>
<affiliation ref="#struct-440815"></affiliation>
</author>
<author role="crp"> <persName> <forename type="first">Jean-Michel</forename>
<surname>Peyrin</surname>
</persName>
<email type="md5">72dfe6bfc4b064476802d66a93ef513b</email>
<email type="domain">upmc.fr</email>
<idno type="halauthorid">1239263</idno>
<affiliation ref="#struct-479809"></affiliation>
</author>
<editor role="depositor"> <persName> <forename>Archive Ouverte</forename>
<surname>ProdInra</surname>
</persName>
<email type="md5">859d2cba2c64f5bbc2add42f2b9992d1</email>
<email type="domain">inra.fr</email>
</editor>
<funder>the French Research National Agency “Agence Nationale de la Recherche,” ANR RPIB “Neuroscreen” and ANR “PrionsensiTNF"</funder>
</titleStmt>
<editionStmt> <edition n="v1" type="current"> <date type="whenSubmitted">2015-10-27 20:23:17</date>
<date type="whenModified">2017-02-02 16:02:33</date>
<date type="whenReleased">2015-10-28 14:40:16</date>
<date type="whenProduced">2013</date>
<date type="whenEndEmbargoed">2015-10-28</date>
<ref type="file" target="https://hal.archives-ouvertes.fr/hal-01221378/document"> <date notBefore="2015-10-28"></date>
</ref>
<ref type="file" subtype="publisherAgreement" n="1" target="https://hal.archives-ouvertes.fr/hal-01221378/file/2013_Deleglise_Plos%20One_%7BAE8659D7-9DFA-463F-BB85-41A72E751883%7D.pdf"> <date notBefore="2015-10-28"></date>
</ref>
</edition>
<respStmt> <resp>contributor</resp>
<name key="132775"> <persName> <forename>Archive Ouverte</forename>
<surname>ProdInra</surname>
</persName>
<email type="md5">859d2cba2c64f5bbc2add42f2b9992d1</email>
<email type="domain">inra.fr</email>
</name>
</respStmt>
</editionStmt>
<publicationStmt> <distributor>CCSD</distributor>
<idno type="halId">hal-01221378</idno>
<idno type="halUri">https://hal.archives-ouvertes.fr/hal-01221378</idno>
<idno type="halBibtex">deleglise:hal-01221378</idno>
<idno type="halRefHtml">PLoS ONE, Public Library of Science, 2013, 8 (8), pp.1-9. <10.1371/journal.pone.0071103></idno>
<idno type="halRef">PLoS ONE, Public Library of Science, 2013, 8 (8), pp.1-9. <10.1371/journal.pone.0071103></idno>
</publicationStmt>
<seriesStmt> <idno type="stamp" n="CNRS">CNRS - Centre national de la recherche scientifique</idno>
<idno type="stamp" n="INRA">INRA - Institut national de la recherche agronomique</idno>
<idno type="stamp" n="UNIV-PARIS5">Université Paris Descartes (Paris 5)</idno>
<idno type="stamp" n="PSL">Paris Sciences et Lettres (PSL) Research University</idno>
<idno type="stamp" n="UPMC">Université Pierre et Marie Curie</idno>
<idno type="stamp" n="CURIE" p="FNCLCC">Institut Curie</idno>
<idno type="stamp" n="PCC_UMR168" p="UPMC">Physico-Chimie Curie</idno>
<idno type="stamp" n="FNCLCC" p="INSERM">UNICANCER</idno>
<idno type="stamp" n="USPC">Université Sorbonne Paris Cité</idno>
<idno type="stamp" n="AGREENIUM">Archive ouverte en agrobiosciences</idno>
</seriesStmt>
<notesStmt> <note type="audience" n="1">Not set</note>
<note type="popular" n="0">No</note>
<note type="peer" n="1">Yes</note>
</notesStmt>
<sourceDesc> <biblStruct> <analytic> <title xml:lang="en">Synapto-protective drugs evaluation in reconstructed neuronal network</title>
<author role="aut"> <persName> <forename type="first">Bérangère</forename>
<surname>Deleglise</surname>
</persName>
<idno type="halauthorid">1239238</idno>
<affiliation ref="#struct-440810"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Benjamin</forename>
<surname>Lassus</surname>
</persName>
<idno type="halauthorid">1239259</idno>
<affiliation ref="#struct-479809"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Vanessa</forename>
<surname>Soubeyre</surname>
</persName>
<idno type="halauthorid">1239241</idno>
<affiliation ref="#struct-479809"></affiliation>
<affiliation ref="#struct-440796"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Aurélie</forename>
<surname>Alleaume-Butaux</surname>
</persName>
<idno type="halauthorid">1239260</idno>
<affiliation ref="#struct-440811"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Johannes J.</forename>
<surname>Hjorth</surname>
</persName>
<idno type="halauthorid">1239261</idno>
<affiliation ref="#struct-440814"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Maeva</forename>
<surname>Vignes</surname>
</persName>
<idno type="halauthorid">1239242</idno>
<affiliation ref="#struct-479809"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Benoit</forename>
<surname>Schneider</surname>
</persName>
<idno type="halauthorid">1239262</idno>
<affiliation ref="#struct-301361"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Bernard</forename>
<surname>Brugg</surname>
</persName>
<idno type="halauthorid">156468</idno>
<affiliation ref="#struct-479809"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Jean-Louis</forename>
<surname>Viovy</surname>
</persName>
<idno type="halauthorid">118899</idno>
<affiliation ref="#struct-440815"></affiliation>
</author>
<author role="crp"> <persName> <forename type="first">Jean-Michel</forename>
<surname>Peyrin</surname>
</persName>
<email type="md5">72dfe6bfc4b064476802d66a93ef513b</email>
<email type="domain">upmc.fr</email>
<idno type="halauthorid">1239263</idno>
<affiliation ref="#struct-479809"></affiliation>
</author>
</analytic>
<monogr> <idno type="halJournalId" status="VALID">28700</idno>
<idno type="issn">1932-6203</idno>
<title level="j">PLoS ONE</title>
<imprint> <publisher>Public Library of Science</publisher>
<biblScope unit="volume">8</biblScope>
<biblScope unit="issue">8</biblScope>
<biblScope unit="pp">1-9</biblScope>
<date type="datePub">2013</date>
</imprint>
</monogr>
<idno type="doi">10.1371/journal.pone.0071103</idno>
<idno type="prodinra">329668</idno>
<idno type="pubmed">23976987</idno>
</biblStruct>
</sourceDesc>
<profileDesc> <langUsage> <language ident="en">English</language>
</langUsage>
<textClass> <classCode scheme="halDomain" n="sdv.mhep">Life Sciences [q-bio]/Human health and pathology</classCode>
<classCode scheme="halDomain" n="sdv.neu">Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]</classCode>
<classCode scheme="halTypology" n="ART">Journal articles</classCode>
</textClass>
<abstract xml:lang="en">Chronic neurodegenerative syndromes such as Alzheimer’s and Parkinson’s diseases, or acute syndromes such as ischemic stroke or traumatic brain injuries are characterized by early synaptic collapse which precedes axonal and neuronal cell body degeneration and promotes early cognitive impairment in patients. Until now, neuroprotective strategies have failed to impede the progression of neurodegenerative syndromes. Drugs preventing the loss of cell body do not prevent the cognitive decline, probably because they lack synapto-protective effects. The absence of physiologically realistic neuronal network models which can be easily handled has hindered the development of synapto-protective drugs suitable for therapies. Here we describe a new microfluidic platform which makes it possible to study the consequences of axonal trauma of reconstructed oriented mouse neuronal networks. Each neuronal population and sub-compartment can be chemically addressed individually. The somatic, mid axon, presynaptic and postsynaptic effects of local pathological stresses or putative protective molecules can thus be evaluated with the help of this versatile “brain on chip” platform. We show that presynaptic loss is the earliest event observed following axotomy of cortical fibers, before any sign of axonal fragmentation or post-synaptic spine alteration. This platform can be used to screen and evaluate the synapto-protective potential of several drugs. For instance, NAD+ and the Rho-kinase inhibitor Y27632 can efficiently prevent synaptic disconnection, whereas the broad-spectrum caspase inhibitor zVAD-fmk and the stilbenoid resveratrol do not prevent presynaptic degeneration. Hence, this platform is a promising tool for fundamental research in the field of developmental and neurodegenerative neurosciences, and also offers the opportunity to set up pharmacological screening of axon-protective and synapto-protective drugs.</abstract>
</profileDesc>
</hal>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Hal/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000980 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Hal/Curation/biblio.hfd -nk 000980 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonFranceV1 |flux= Hal |étape= Curation |type= RBID |clé= Hal:hal-01221378 |texte= Synapto-protective drugs evaluation in reconstructed neuronal network }}
![]() | This area was generated with Dilib version V0.6.29. | ![]() |